Nat Immunol:发现血管硬化过程中引起血管炎症的新机制

2013-09-09 张峰 生物谷

在肥胖,糖尿病,心血管病等代谢紊乱疾病中,慢性炎症是基本症状和病因之一。胆固醇晶体是引起无菌炎症的代谢信号,而且科学家推测,该信号通过刺激IL-1β释放,激活炎症小体来介导血管炎症反应的发生,并最终导致动脉硬化。而最近,美国的研究者发现,IL-1α介导了动脉硬化的发生,还发现脂肪酸是IL-1α介导的血管炎症的诱因。脂肪酸通过解耦联线粒体上的呼吸链,阻断了IL-1β的分泌,从而阻断了胆固醇晶体引起的

在肥胖,糖尿病,心血管病等代谢紊乱疾病中,慢性炎症是基本症状和病因之一。胆固醇晶体是引起无菌炎症的代谢信号,而且科学家推测,该信号通过刺激IL-1β释放,激活炎症小体来介导血管炎症反应的发生,并最终导致动脉硬化。而最近,美国的研究者发现,IL-1α介导了动脉硬化的发生,还发现脂肪酸是IL-1α介导的血管炎症的诱因。脂肪酸通过解耦联线粒体上的呼吸链,阻断了IL-1β的分泌,从而阻断了胆固醇晶体引起的炎症反应,使巨噬细胞选择性释放IL-1α。这项研究发现了代谢应激引起的血管免疫病理的新机制,并且暗示着在对血管硬化病人治疗中,应该针对IL-1α而非IL-1β。【原文下载

生物谷推荐英文摘要:

Nature immunology    doi:10.1038/ni.2704

Fatty acid–induced mitochondrial uncoupling elicits inflammasome-independent IL-1a and sterile vascular inflammation in atherosclerosis

Stefan Freigang1, Franziska Ampenberger1, Adrienne Weiss2, Thirumala-Devi Kanneganti3, Yoichiro Iwakura4, Martin Hersberger2 & Manfred Kopf1

Chronic inflammation is a fundamental aspect of metabolic disorders such as obesity, diabetes and cardiovascular disease. Cholesterol crystals are metabolic signals that trigger sterile inflammation in atherosclerosis, presumably by activating inflammasomes for IL-1b production. We found here that atherogenesis was mediated by IL-1a and we identified fatty acids as potent inducers of IL-1a-driven vascular inflammation. Fatty acids selectively stimulated the release of IL-1a but not of IL-1b by uncoupling mitochondrial respiration. Fatty acid–induced mitochondrial uncoupling abrogated IL-1b secretion, which deviated the cholesterol crystal–elicited response toward selective production of IL-1a. Our findings delineate a previously unknown pathway for vascular immunopathology that links the cellular response to metabolic stress with innate inflammation, and suggest that IL-1a, not IL-1b, should be targeted in patients with cardiovascular disease.

原文下载

Freigang S, Ampenberger F, Weiss A, Kanneganti TD, Iwakura Y, Hersberger M, Kopf M.Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.Nat Immunol. 2013 Sep 1.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1691257, encodeId=cf6e169125e30, content=<a href='/topic/show?id=378089e311a' target=_blank style='color:#2F92EE;'>#血管硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89731, encryptionId=378089e311a, topicName=血管硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae529209097, createdName=jiyangfei, createdTime=Mon Sep 16 13:43:00 CST 2013, time=2013-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879665, encodeId=0f8d18e9665f5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Aug 15 21:43:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263149, encodeId=f64112631491b, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Sep 11 06:43:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479166, encodeId=a88b14e916646, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Wed Sep 11 06:43:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1691257, encodeId=cf6e169125e30, content=<a href='/topic/show?id=378089e311a' target=_blank style='color:#2F92EE;'>#血管硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89731, encryptionId=378089e311a, topicName=血管硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae529209097, createdName=jiyangfei, createdTime=Mon Sep 16 13:43:00 CST 2013, time=2013-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879665, encodeId=0f8d18e9665f5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Aug 15 21:43:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263149, encodeId=f64112631491b, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Sep 11 06:43:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479166, encodeId=a88b14e916646, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Wed Sep 11 06:43:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
    2014-08-15 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1691257, encodeId=cf6e169125e30, content=<a href='/topic/show?id=378089e311a' target=_blank style='color:#2F92EE;'>#血管硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89731, encryptionId=378089e311a, topicName=血管硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae529209097, createdName=jiyangfei, createdTime=Mon Sep 16 13:43:00 CST 2013, time=2013-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879665, encodeId=0f8d18e9665f5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Aug 15 21:43:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263149, encodeId=f64112631491b, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Sep 11 06:43:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479166, encodeId=a88b14e916646, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Wed Sep 11 06:43:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1691257, encodeId=cf6e169125e30, content=<a href='/topic/show?id=378089e311a' target=_blank style='color:#2F92EE;'>#血管硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89731, encryptionId=378089e311a, topicName=血管硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fae529209097, createdName=jiyangfei, createdTime=Mon Sep 16 13:43:00 CST 2013, time=2013-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879665, encodeId=0f8d18e9665f5, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Aug 15 21:43:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263149, encodeId=f64112631491b, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Sep 11 06:43:00 CST 2013, time=2013-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479166, encodeId=a88b14e916646, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Wed Sep 11 06:43:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]